Space Tango

What Space Tango does

Space Tango is a Lexington, Kentucky-based private company (founded 2014) that designs and operates automated hardware and software platforms for research and manufacturing in microgravity. Its core product family centers on CubeLabs — standardized automated platforms scaling from 1U to 9U+ that house experiments aboard the International Space Station — supplemented by Mambo (large-volume in-space manufacturing platform), PAUL (powered ascent platform preserving biological viability from launch through docking), Studio (fully automated laboratory with multi-modal imaging), TangoScope (automated fluorescence microscope), and TangoBox (robotic laboratory hood under NASA SBIR Ignite development). The platforms include built-in flight computers, thermal control to 4°C, and near-real-time data delivery to partners, enabling autonomous operation independent of crew time. Space Tango has completed 290+ investigations across 35+ missions delivered via SpaceX CRS, Northrop Grumman Cygnus, and crewed launches.

The company serves four primary segments: biotechnology and pharmaceutical companies (e.g., LambdaVision for artificial retina manufacturing, Emulate Bio for organ-on-chip studies, Auxilium for bioprinting, Encapsulate for tumor-on-chip), academic medical centers and research institutions (Massachusetts General Hospital, Cedars-Sinai, UC San Diego, Sheba Medical Center), government space agencies (NASA Artemis II and BPS division contracts), and advanced manufacturing customers. Revenue is generated through custom-quoted enterprise contracts — government grants and SBIR awards, per-mission research service fees with biotech and pharma partners, and longer-term production partnerships (e.g., NASA Phase II InSPA). Distribution is direct enterprise sales and formal government contracting, with no public pricing tiers.

Space Tango operates as the in-space research and manufacturing layer between launch providers (SpaceX, Northrop Grumman) and end-user science partners, with visible positioning for the post-ISS commercial LEO era through relationships with Vast, Starlab, and Axiom. In 2022 the company acquired Faradine Space Systems to deepen automation capabilities, and in 2023 S. Sita Sonty joined as CEO with co-founder Twyman Clements transitioning to President. Cumulative NASA and grant funding exceeds $60M, anchored by an approximately $5M Artemis II award in 2024 and ongoing mission work supporting cancer research, regenerative medicine, protein crystallization, and 3D bioprinting applications.

Name

Space Tango

Legal name

Space Tango LLC

Website

https://spacetango.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

Space Tango designs and operates automated hardware platforms (CubeLabs, Mambo, PAUL, Studio) for microgravity research and manufacturing aboard the ISS and beyond, serving NASA, biotech and pharma companies, academic medical centers, and advanced manufacturers through custom enterprise contracts.

Ownership category

akta.pro rank

Product category

Microgravity Research and Manufacturing Services

NAICS

Other Guided Missile and Space Vehicle Parts and Auxiliary Equipment Manufacturing (336419)

SIC

Guided Missiles & Space Vehicles & Parts (3760)

akta.pro primary industry

Spacecraft Avionics, Flight Computers & Software (IMABACAI)

akta.pro secondary industry

Robot Software, Autonomy Stacks & Simulation (ROS, digital twins) (HDAAAIAK)

Keywords

• Microgravity research platforms
• In-space biomanufacturing
• Automated orbital laboratories
• Space-based research services
• ISS payload integration

Headquarters

HQ city

Lexington

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

1. Government Research Contracts: Space Tango generates significant revenue through NASA contracts including SBIR awards, BPS division contracts, and Artemis mission support. The company was awarded approximately $5 million from NASA for Artemis II biological data collection support and has received over $60M through NASA and additional grant programming.
2. Commercial Research Partnerships: Partnering with biotech and pharmaceutical companies to conduct microgravity research and manufacturing. Services include providing automated CubeLab platforms, launch integration, on-orbit operations, and data return. Revenue generated through per-mission fees and long-term partnership agreements.
3. Manufacturing Services: Providing microgravity manufacturing capabilities for high-value products like artificial retinas, 3D-printed medical devices, and materials requiring superior uniformity. Revenue from production fees and technology licensing for space-manufactured products.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Space Tango designs, builds, and operates automated hardware platforms (CubeLabs, Mambo, PAUL, Studio, TangoBox) that enable microgravity research and in-space manufacturing on the ISS and future orbital destinations. The company provides end-to-end mission services including hardware development, launch integration, on-orbit operations, and data return for pharmaceutical, biotech, academic, and government partners. Its CubeLab trademark line scales from 1U to 9U+ configurations and supports over 290 completed investigations across 35+ missions.

Product overview

Space Tango operates as a space infrastructure company offering a portfolio of automated platforms and hardware for microgravity research and manufacturing. The core product line centers on CubeLabs, standardized automated systems that scale from 1U to beyond 9U configurations, which are installed in the TangoLab facility aboard the ISS and other platforms. Supporting products include Mambo (large-volume manufacturing platform), PAUL (powered ascent/return locker), and Studio (fully automated laboratory with multi-modal imaging). TangoBox provides robotic laboratory hood capability, while subsystems like the Cold Flask (temperature control to 4°C) and CubeLab Flight Computer enable autonomous operations. TangoScope adds fluorescence microscopy capability. The company serves partners across pharmaceuticals, biotechnology, materials science, and academic research through payload integration, mission operations, and data services.

Differentiator

Problem solved

Functional benefit

Brands

• CubeLabs: Automated R&D and manufacturing platform for research in remote environments, scaling from 1U to larger configurations.
• Mambo
• PAUL
• Studio
• TangoLab
• TangoScope
• TangoBox

Products and services

• CubeLabs
• Mambo
• PAUL (Powered Ascent Utility Locker)

Quantifiable outcome

• Superior layer uniformity and optical clarity achieved in artificial retina manufacturing compared to Earth-based production due to absence of gravity-driven sedimentation
• +3 more outcomes

Named customers10 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

14 partnerships are on record, tiered minor, core and key.

• Quest Institute for Quality EducationminorStrategic or Co-development Partner · 14 September 2025Student-led investigation featuring 16 experiments exploring magnetism, fluid mechanics, microbial behavior, plant growth, and materials science in microgravity. Students customize experiments and conduct parallel Earth studies through Quest Institute's STEM education initiatives.
• LambdaVisioncoreStrategic or Co-development Partner · 10 September 2025Long-standing partnership for manufacturing protein-based artificial retinas aboard the ISS. Space Tango designs, builds, and operates microgravity-optimized layer-by-layer deposition devices for LambdaVision's artificial retina production. Partnership spans 9+ flights with planned continuation for clinical trial preparation and production scale-up. NASA Phase II InSPA award enables further process optimization in low-Earth orbit.
• UC San Diego (Muotri Lab, Jamieson Lab)coreStrategic or Co-development Partner · 24 August 2025Multiple investigations including brain organoid research studying microgravity effects on neurological development, aging, and disease; hematopoietic stem cell research through the ISSCOR project studying blood cancer mechanisms. Space Tango provides automated CubeLab platforms for these long-duration investigations.
• Encapsulate Inc.keyStrategic or Co-development Partner · 24 August 2025Partnership for tumor-on-a-chip systems to forecast chemotherapy responses using patient-derived microtumors in microgravity. Space Tango provides high-capacity CubeLab platforms for these investigations enabling parallel studies with ground controls.
• Higher OrbitsminorStrategic or Co-development Partner · 24 August 2025Nonprofit organization using space exploration excitement for STEM education through Go For Launch! camps. Student-designed experiments studying algae, slime mold, mealworms, and legumes in microgravity housed in Space Tango's CubeLab.
• Sheba Medical Center / ARC Space LabkeyStrategic or Co-development Partner · 31 July 2025International partnership investigating how space environment affects bacteria causing food poisoning and gastrointestinal infections. Space Tango engineered automated CubeLab to study virulence pathways in enteric bacterial pathogens with parallel Earth-based controls. Samples successfully returned for detailed post-flight analysis.
• Massachusetts General Hospital (MGH)coreStrategic or Co-development Partner · 22 April 2025Strategic collaboration focused on pioneering advanced medical research in microgravity with emphasis on cancer research. The partnership uses Space Tango's automated solutions on the ISS, future commercial space stations, and re-entry capable cargo capsules. Both organizations committed to sharing findings with the global scientific community and accelerating translation of research into health benefits.
• Auxilium BiotechnologiescoreStrategic or Co-development Partner · 5 December 2024Partnership for 3D bioprinting of drug-delivery medical devices in microgravity using Auxilium's AMP-1 bioprinter aboard Space Tango's Mambo facility. Successfully manufactured the NeuroSpan Bridge nerve regeneration device - first DLP bioprinter operation on ISS. Funded by NASA InSPA for regenerative medicine applications.
• Sachi BioWorksminorStrategic or Co-development Partner · 4 November 2024Rapid, low-cost drug discovery investigation evaluating whether microgravity and radiation can accelerate aging and neurodegeneration for more efficient therapeutic development. Uses Space Tango CubeLab platform for organoid studies.
• Magnitude.iominorStrategic or Co-development Partner · 4 November 2024ExoLab-11 investigation studying plant growth in microgravity for space agriculture applications. Student experiments comparing space and Earth-based growth with educational outreach to schools and citizen scientists.
• University of Texas at El Paso / Oregon State UniversityminorStrategic or Co-development Partner · 4 November 2024Joint investigation studying effects of microgravity on cardiac organoid cultures and bioprinted heart tissue. First examination of bioprinting cardiac tissue in microgravity for understanding cardiac atrophy mechanisms.
• MIT Space Exploration InitiativekeyTechnology or Integration · 4 April 2024Space Tango providing space integration and flight readiness analysis to MIT's initiative targeting flight-ready applications through parabolic flight program. Sponsorship of Beyond the Cradle conference supporting next generation of spaceflight research.
• Cedars-SinaikeyStrategic or Co-development Partner · 30 January 2024Third and final investigation examining effect of microgravity on induced pluripotent stem cells (iPSCs) for gene therapy development. Space Tango provides automated CubeLab capabilities for stem cell research advancing regenerative medicine timelines.
• Emulate BiocoreTechnology or Integration · 1 December 2018Partnership for Organs-on-Chips investigations aboard the ISS using Space Tango's automated CubeLab platforms. Space Tango developed the TangoScope, a novel 3-axis fluorescence microscope for tissue chip imaging in microgravity. Partnership enables studies of brain, gut, and other organ chips to understand human physiology in space with four missions completed.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Redwire Corporation: Public space infrastructure company offering in-space manufacturing, biotech payloads (including ROSA solar arrays and 3D bioprinting) and ISS payload services; the closest direct competitor to Space Tango in commercial microgravity research and biomanufacturing platforms.
• NanoRacks (Voyager Space): Pioneer of commercial ISS payload services with Bishop Airlock and standardized CubeLab-style experiment platforms; competes directly with Space Tango for biotech and academic microgravity research customers.
• Axiom Space: Building the world's first commercial space station and offering microgravity research and in-space manufacturing services; a primary destination competitor as ISS retires and a potential partner/customer for Space Tango-style research payloads.
• SpacePharma: Israeli startup providing end-to-end microgravity experiment services using miniature autonomous labs on ISS and suborbital flights; competes for pharma/biotech microgravity research budgets.
• Rhodium Scientific: Space biology and biotech services company running microgravity research campaigns on ISS for life sciences customers; small, niche competitor in the same B2B research-as-a-service category.
• BioServe Space Technologies: University of Colorado research center designing and flying life-science hardware on ISS for government and industry partners; comparable model of automated payload development for biotech and academic customers.

Emerging players

• Vast Space: Developing commercial space stations with built-in research and manufacturing facilities; features on Space Tango's own partner page, signaling overlap in target customers for in-orbit biotech and materials science research.
• Starlab (Voyager–Airbus): Joint venture commercial space station with explicit George Washington Carver science park for in-space biomanufacturing; an emerging alternative destination for the same research customers Space Tango serves today.

Broad incumbents

• Sierra Space: Major space infrastructure prime building Dream Chaser and LIFE habitat for in-space manufacturing; a broader incumbent that competes for both station contracts and research payload programs.

Others

• LambdaVision: Space Tango's flagship commercial partner using microgravity to manufacture protein-based artificial retinas; included as an adjacent ecosystem player illustrating the customer relationship and downstream biomanufacturing economics.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/space_tango
• Facebookfacebook.com/spacetangopage
• LinkedInlinkedin.com/company/spacetango
• Instagraminstagram.com/space_tango

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Space Tango